Work at Emory University has led to the development of peptidomimetic compounds acting as protease (viral) inhibitors reported to be useful for the treatment of viral infections.

Academy of Military Medical Sciences (AMMS) has divulged 3C-like proteinase (viral) and 3C protease (viral) inhibitors reported to be useful for the treatment of viral infections.